See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new pre-exposure prophylaxis (PrEP) drug has shown promise as a ...

TV personality Michelle Visage lends her voice to raise awareness about important differences in long-acting injectable PrEP options More information and resources for people who could benefit from ...

The Illinois Department of Public Health has issued a standing order that will allow residents to obtain the HIV preventive medication known as PrEP (pre-exposure prophylaxis) directly from a ...

For the first time, an HIV PrEP drug candidate has shown zero infections in a phase 3 trial. The result came from the PURPOSE 1 trial evaluating Gilead Sciences’ twice-yearly, subcutaneous lenacapavir ...

Erin O'Malley, the PReP for HIV program navigator, provides testing, contraceptives, and education to help people in McLean ...

The FDA approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at-risk adults and adolescents, Gilead Sciences announced on Wednesday. An ...

HOUSTON — The fight against HIV has come a long way, and new advancements in prevention are changing the game. One of the latest breakthroughs is a long-lasting injectable form of PrEP (pre-exposure ...

(RTTNews) - Gilead Sciences Inc. (GILD) announced that the U.S. Food and Drug Administration has approved Yeztugo (lenacapavir)-the company's injectable HIV-1 capsid inhibitor-as pre-exposure ...

Add Yahoo as a preferred source to see more of our stories on Google. Lenacapavir is now approved to prevent HIV infection as well as to treat certain infections. - Gilead Sciences Inc. A drug ...

Witkoppen Clinic says the long-acting Lenacapavir injection gives eligible patients a convenient alternative to daily HIV ...

Right now, more than 13% of HIV-positive people in Shelby County don’t even know they’re infected.